Cipla SA has been awarded a R345 million share of the national respiratory tender.
This is the second largest Government tender awarded to Cipla in the last three years, following the ARV tender the company won in 2012.
“This successful tender is yet again testament to the Cipla team’s commitment to excellence and quality, and the company ethos of advancing healthcare for all,” says Cipla CEO, Paul Miller.
“We firmly believe the pharmaceutical industry’s role in alleviating respiratory ailments should be to support Government through patient education, training healthcare workers to enable them to deliver better care and to provide high quality affordable medicine.”
“Ultimately, patients across the country will benefit from increased access to Cipla’s respiratory programmes and products.”
For more read the Business Report online article here.
In the interest of our patients, in accordance with South African law and our commitment to expertise, MediHub cannot subscribe to the practice of online diagnosis. Please consult a medical professional for specific medical advice. If you have any major concerns, please see your doctor for an assessment. If you have any cause for concern, your GP will be able to direct you to the appropriate specialists.